Contrast-enhanced small-animal computed tomography is an economical and highly quantitative tool for serially examining tumor development in situ, for analyzing the network of blood vessels that nourish them, and for following the response of tumors to preclinical therapeutic intervention(s). We present practical considerations for visualizing the vascular network of transgenic mouse tumors. Using a long-acting iodinated triglyceride blood-pool contrast agent, we present optimized scanner acquisition parameters and volume-rendering techniques for examining the intermediate and large vessels of complex spontaneous tumors (e.g., alveolar rhabdomyosarcomas) in transgenic mice. Our findings indicate that multiple-frame, 360 -720 view acquisitions were mandatory for clarifying bone and soft tissue from vessel contrast. This finding was consistent in visualizations using a one-dimensional transfer function where voxel color and opacity was assigned in proportion to CT value and a two-dimensional transfer function where voxel color and opacity was assigned in proportion to CT value and gradient magnitude. This study lays a groundwork for the qualitative and quantitative assessment of anti-angiogenesis preclinical studies using transgenic mice. Mol Imaging (2005) 4, 417 -424.
Introduction
Transgenic mouse models of human cancer have the potential to be more reflective of human cancers than xenograft models because transgenic mice form tumors in situ, (i.e., in an environment more similar to the human tumor and in the setting of a normal immune system). Small-animal X-ray computed tomography (microCT) is an economical and highly quantitative three-dimensional method for visualizing blood vessels and angiogenesis preclinically [2, 9] even in comparison to small-animal magnetic resonance imaging [6] . The goal of this study was to develop practical guidelines for rapid, accurate visualization of intermediate to large caliber (>93 mm) blood vessels for serial assessment of vascularity during preclinical therapeutic trials in living mice. The limitations caused by long scan times for most small-animal CT studies were overcome by using a long-acting blood-pool contrast agent [12] . In this study, we assessed vessels by qualitative visual renderings, although the same optimized acquisition settings would be necessary for quantitative analysis of tumor blood volume, vessel density, vessel caliber, degree of branching, and tortuosity using segmentation analysis.
Materials and Methods

Computed Tomography Scanning
All animals used for this study were treated in accordance with an IACUC approved protocol. Live mice were injected with 0.4 mL/25 g of a 50-mg iodine/mL 150-nm particle diameter iodinated triglyceride bloodpool contrast agent [12] (Fenestra VC; Alerion Biomedical, San Diego, CA) into the distal tail vein using a 25-or 27-gauge needle. Both wild-type C57BL/6 mice and transgenic mice harboring a conditional knock-in of the Pax3:Fkhr oncogene, causing alveolar rhabdomyosarcomas, were utilized [5] . Mice were anesthetized with an intraperitoneal injection of 0.3-1 mL/25 g of 2.5% Avertin depending upon whether survival or sacrifice was intended. For minimization of movement artifacts, mice were placed in a custom-built, commercially available isolator (CH Technologies, Westwood, NJ) with continuous airflow delivered by a generic fish tank pump. Volumetric CT of anesthetized mice was performed at 93 mm 3 voxel resolution using an eXplore (http://ccri.uthscsa.edu). In this study, the platformindependent parameters of current, voltage, and exposure time were kept constant at 430 mA, 80 kV, and 100 msec, respectively. The number of views varied between 180 and 720 and was evenly spaced. The number of frames per view was varied from 1 to 8. Images were reconstructed with the manufacturer's proprietary EVSBeam software, and preliminary visualizations (not shown) were generated with the open-source MicroView program (http://microview.sf.net).
Image Rendering
The tomography volume files computed by the EVSBeam software were processed with the open-source utilities in Teem (http://teem.sf.net) to generate the slice images, histograms, and volume renderings in the following figures. Other than cropping to the region of interest (head and torso), no other filtering or smoothing was applied to the data. The volume renderings were computed with a standard brute-force ray-casting algorithm, using the framework presented by Levoy [8] , which proceeds as follows: for each pixel in the rendering, a geometric ray is cast through the CT volume according to the virtual camera position, and the CT values and gradient vectors are densely sampled along the rays. The gradient vectors are the basis of the synthetic shading which conveys local surface orientation. The value and gradient measurements are performed by convolving the discrete CT volume samples with separable continuous kernels, as described by Möller et al. [10] . For this study we used the Catmull-Rom kernel for value measurement, and the derivative of the uniform cubic B-spline for derivative measurement. Other than early ray termination after hitting a nearly completely opaque region, no optimizations or approximations are employed, resulting in a highly accurate, though computationally intensive, rendering. The computation for each horizontal row of pixels was distributed across 64 CPUs of an SGI Onyx 3800 in a first-come-first-serve manner, resulting in a total rendering time of approximately 1 min. The beta-test of a bundled, graphic user interface (GUI)-based software package encompassing all the abovementioned algorithms was used to generate preview renderings.
Colors and opacities are assigned to the ray sample according to the transfer function, which is parameterized by either CT value (in the case of 1-D transfer functions), or both CT value and gradient magnitude (in the case of 2-D transfer functions). Transfer functions were manually adjusted based on guidance provided by CT value histograms (Figure 1 ). For this study, the strategy of 1-D transfer function adjustment was to assign maximal opacity to the broadest range of high CT values (belonging to bone), without impinging on the range of CT values associated with soft tissue. Reducing tomography artifacts significantly facilitates this particular task, by narrowing the value ranges associated with each material (Figure 2 ). For 2-D transfer functions, the transfer functions were created with guidance from a joint histogram of CT value and gradient magnitude, based on the considerations outlined by Kindlmann and Durkin [7] . Anatomical landmarks were verified with an atlas of surface and cross-sectional mouse anatomy [3] .
Results
Vessel Identification is Critically Dependent upon Accurate Soft Tissue Identification and Differentiation from Bone
Tumors in transgenic mice are inherently different from xenografts because the transgenic mouse tumors are often intermingled with bony structures instead of lying in the soft tissue flank. Therefore, vessel imaging in transgenic mouse tumors represents a new paradigm. To determine the best scanner acquisition settings for accurate rendering and visualization of blood vessels from the microCT dataset, we first performed serial scans with different settings on a wild-type C57BL/6 control mouse that had undergone a tail vein injection of 0.4 mL iodinated triglyceride contrast agent (50 mg iodine/mL) 5 min before euthanasia. We used evenly spaced views about a full gantry rotation because prior experience with partially circumferential imaging led to unacceptable artifacts (data not shown). Our instrument is capable of resolutions between 27 and 93 mm isotropic voxel resolution; however, because the higher resolution would decrease the field of view and would increase the radiation dose to the animal above 200 Roentgens (R), we chose to use 93 mm resolution (<55R) for this initial study. We anticipated that the use of larger voxels would also lead to minor overestimation of vessel diameters as a result of partial volume effects (e.g., a single voxel partially residing in vessel would be classified as wholly vessel).
With views every 2 degrees of rotation (180 views total), a cogwheel-appearing aliasing artifact of reconstruction was apparent because of too few views ( Figure 1A ). However, by increasing the number of views to 360 or 720, this artifact dissipated, and by increasing the number of frames averaged per view from 1 to 8, the boundaries of vessels in the neck became increasingly distinct qualitatively (as signal-to-noise improved). Because the blood contrast agent density was intermediate between bone and soft tissue, we examined the separation of density values (CT values) between soft tissue and bone in a control animal not injected with contrast. We observed the unexpected phenomena that although soft tissue CT values fall into a distinct peak, bone CT value falls into an indistinct ''tail.'' This can be seen by in linear (white) and logarithmic (gray) scale. A rendering of bone, whereby increased opacity is assigned to voxels with high CT values, is shown to the right of each histogram in (B) and (C). At 1 frame per view, the soft tissue peak is wide and therefore a subset of soft tissue voxels are misclassified as bone in both the histogram (B, left) and the rendering (B, right). At 8 frames per view (C), the soft tissue peak becomes narrower, allowing better distinction between soft tissue and bone. As a result, misclassification is greatly reduced, so that although opacity is assigned to bone, no opacity is assigned to soft tissue thereby clarifying the volume rendering.
Note that the bone CT values are a ''tail,'' rather than a peak. (D) In a separate animal injected with the iodinated triglyceride contrast agent, the contrast peak (labeled ''blood'') is intermediate to soft tissue and bone, but an appropriate threshold can be chosen to distinguish soft tissue from vascular contrast agent and bone. h, heart.
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inspection of the histogram of CT values in Figure 1B . The main peak in the histogram, signifying the most common material, is that of non-contrast-enhanced soft tissue. Bone does not constitute a discernible histogram peak because of both the relatively insignificant number of voxels with bone (due to the thinness of bone), and the widely varying opacities attributable to bone (due to varying bone thickness and density, combined with partial volume effects). Based on these considerations, a high-quality scan is one in which the width of the peak attributed to soft tissue is minimized. This in turn minimizes misclassification of soft tissue voxels and contrast-containing blood vessel voxels during application of volume-rendering transfer functions. The improved distinction between soft tissue and bone with increasing frames per view was demonstrated by choosing the best volume-rendering threshold between the ''peak'' of soft tissue CT values and the ''tail'' of bone CT values using the 1 frame per view scan versus the 8 frames per view scan ( Figure 1B and C, respectively) . At the higher number of frames per view, with a different animal injected with intravenous contrast, a clear distinction between soft tissue and vessel-contrastplus-bone could be made ( Figure 1D ). Note that the CT values of the blood contrast agent are found in a distinct peak when 8 frames/view are used, but it would not have been distinguishable from the wider soft tissue peak of the 1 frame/view scan.
Improving the Signal-to-Noise Ratio of Soft Tissue Requires Longer Scan Times with Increased Numbers of Views and Number of Frames per View
We had hoped that a quality scan for a large field of view could be achieved in less than 20 min so that the duration of anesthesia could be minimized and the throughput of animals maximized. Our goal in performing a test set of scans varying in the number of views and the number of frames/view in a euthanized animal (Figure 2 ) was to find settings that required the least amount of time but resulted in the narrowest peak of soft tissue CT values. The settings that were most optimal for distinguishing soft tissue, vessel contrast, and bone in subsequent transfer functions for rendering were the 21 min 360 view, 8 frame/view settings and the 24 min 720 view, 4 frame/view settings. The 13 min 360 view, 4 frame/view settings was nearly, but not completely acceptable for subsequent renderings (data not shown). Although not an intended element of this study, we observed (Figure 2 ) that the histogram peak attributable to contrast-enhanced vessels seems to increase in width (with a corresponding decrease in height) in the animal following death, suggesting a postmortem diffusion process. This phenomenon would not be expected to occur in live animals, although in live mice the iodinated triglyceride is known to slowly be taken up by the liver over a period of hours [12] . Figure 3B , left) appears to have an undesirable red haze overlying the bone cortex. However, using a 2-D transfer function that assigns red color and intermediate opacity to voxels based upon both the CT value and gradient magnitude ( Figure 3A, right) , the resulting rendering distinguishes bone and vessel contrast more accurately ( Figure 3B, right) .
Given the significantly improved ability to differentiate vessel contrast from bone using a 2-D transfer function instead of a 1-D transfer function, we examined whether less robust scanning parameters could be used with a 2-D transfer function and still accurately distinguish iodinated triglyceride contrast from bone ( Figure 3C ). We found that the optimal, 21 -24 min scan parameters were still required to prevent misclassification of vessel contrast as bone in control mice.
Even with a 2-D Transfer Function, Optimal Scan Acquisition Parameters are Necessary
Using optimized scan parameters (360 views, 8 frame/ view), vascular imaging of a large Pax3:Fkhr expressing rhabdomyosarcoma of the lower extremity could be effectively performed on a living mouse that survived the scan, demonstrating arterial and venous vessels with complex branching patterns ( Figure 4A ). At this resolution, capillary networks could be visualized collectively but individual capillaries could not be distinguished. For comparison, we performed a 720-view, 4 frame/view scan of a different transgenic tumor-bearing mouse that survived the scan ( Figure 4B ) demonstrating a neck tumor arising from the left sternocleidomastoid. The hypoxic nature of this collagen-rich tumor is evident from its avascularity, yet it aggressively displaces the adjacent normal vessels. We also note that at this resolution (93 mm 3 ) the thin-walled, large lumen venous vessels are more easily visualized than corresponding the thicker-walled, smaller lumen arterial vessels that run adjacent to them ( Figure 4C ). Another limitation is that thin-cortex bones, such as the scapula ( Figure 4C ), were still misclassified as contrast agent. Overall, however, renderings of transgenic mouse tumors are generally very informative when optimized scan settings are used in combination with a 2-D transfer function. As a practical note, the 0.4-mL dose of iodinated triglyceride intravenous contrast is generally well tolerated by mice, but similar results can be achieved with the same scanner parameter settings and a lower 0.2-0.3 mL dose of the contrast agent.
Discussion
The primary goal of this microCT study was to determine optimal techniques for generating quality datasets for analysis of tumor vascular networks in live mice that would be serially scanned. Establishing the minimum necessary, platform-independent scanner parameter settings was accomplished through a combination of histogram analysis and qualitative evaluation of volume renderings. A secondary goal of this study was to demonstrate, through volume rendering, the quality and resolution of the anatomical imaging possible with a long-acting blood pool contrast agent. For both goals, multiple-frame, 360-720 view acquisitions were mandatory for clarifying bone and soft tissue from vessel contrast. This study is a necessary prelude to subsequent quantitative image analysis where signal-to-noise and boundary delineation are critical (e.g., modeling of vasculature network using image segmentation). Improvements in CT technology are likely to make vessel imaging in transgenic mouse models easier, faster, and more accurate over time. Already, commercially available (but substantially more expensive) scanners exist which can scan an entire mouse at 150 mm isotropic voxel resolution in under 2 sec [6] . This rapid acquisition is useful not only for studying tumor vessel anatomy, but enables study of tumor perfusion and vascular permeability as well. When this acquisition speed can be achieved for higher spatial resolution (15 mm), the ability to study vasculoneogenesis of small arterioles in tumors will be significantly improved. Faster acquisitions will also enable the use of short-lived (clinical), highiodine content contrast agents instead of low-iodine content blood pool contrast agents, although our experience suggests that contrast agents of intermediate density between soft tissue and bone may be most advantageous in the identification of contrast-enhanced vessels. On this note, a continuous (25 min) intravenous infusion of a smaller volume (< 0.2 mL) of clinical contrast agent would be likely be as effective with current microCT scanners as the blood-pool contrast agent used in this study.
By the high-resolution nature of small-animal imaging, mouse models of human tumors are expected to lead and guide clinical studies of tumor vascular biology and anti-angiogenesis therapies which target capillaries.
Although xenograft models have been very informative for studying basic mechanism of angiogenesis, orthotopic or spontaneous/in situ (transgenic) mouse models will more accurately reflect host organ effects and are expected to more accurately predict response of human tumors [1] . In 2001, Jain [4] very rightly pointed out the need for better noninvasive imaging in anti-angiogenesis clinical trials, whereby response measures such as vessel diameter, vessel tortuosity, vessel density, vascular permeability, partial pressure of oxygen, and interstitial pressure could be measured. Direct visualization of capillaries is not yet possible with current instruments because the resolution required would exceed both a safe radiation dose and a safe anesthesia duration for a living mouse. To analyze angiogenesis with current technology, one would rely on surrogate markers such as total tumor contrast-enhanced blood volume, or change in the structure of amalgamated capillary networks as they appear in scans at 46 -93 mm resolution ( Figure 4A ). With anticipated advances in instrumentation, X-ray CT holds the best potential to define anatomical measures of vessel diameter, tortuosity, and density for tumors whose capillary diameters can range from 11 to 15 mm [11] . Other modalities such as magnetic resonance may be equally or better suited to defining tumor boundaries, permeability, oxygenation, and interstitial pressure. Therefore, co-registration of serial multimodality images of the same tumor may become the standard for preclinical and clinical anti-angiogenesis studies. A great deal of work remains to be done for instrumentation development, scan optimization, and postprocessing analysis, but the field is off to an encouraging start.
